These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 1385356)

  • 1. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection.
    Morris D; Ansar M; Speshock J; Ivanciuc T; Qu Y; Casola A; Garofalo R
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31398832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies.
    Streckert HJ; Philippou S; Riedel F
    Arch Virol; 1996; 141(3-4):401-10. PubMed ID: 8645083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A; Tanaka-Taya K; Ueda S
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
    Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
    J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization.
    Dickey C; Ziegner U; Agadjanyan MG; Srikantan V; Refaeli Y; Prabhu A; Sato A; Williams WV; Weiner DB; Ugen KE
    DNA Cell Biol; 2000 Apr; 19(4):243-52. PubMed ID: 10798448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitopes at the proteolytic cleavage sites of HIV-1-gp120 and RSV-F protein share a sequence homology: comparative studies with virus-induced and antipeptide antibodies.
    Streckert HJ; Werchau H
    Intervirology; 1992; 34(1):30-7. PubMed ID: 1385356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of animal viruses.
    Dimmock NJ
    Curr Top Microbiol Immunol; 1993; 183():1-149. PubMed ID: 8354080
    [No Abstract]   [Full Text] [Related]  

  • 10. Human monoclonal antibodies: recent achievements.
    Burton DR; Barbas CF
    Hosp Pract (Off Ed); 1994 Nov; 29(11):111, 114-6, 119 passim. PubMed ID: 7962228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of peptides by antibodies and investigations of affinity using biosensor technology.
    Van Regenmortel MH; Choulier L
    Comb Chem High Throughput Screen; 2001 Aug; 4(5):385-95. PubMed ID: 11472227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-antigen interactions: new structures and new conformational changes.
    Wilson IA; Stanfield RL
    Curr Opin Struct Biol; 1994 Dec; 4(6):857-67. PubMed ID: 7536111
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.